As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

In the middle of September I started taking Wegovy, and in that time I have ... Sir Alec said around 500,000 people are using weight-loss injections and acknowledged some have experienced negative ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

A study has suggested that weight-loss injections may be linked to broader ... discovered that participants who used drugs such as Wegovy and Ozempic had a lower risk of 42 health conditions ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

The key drugs in the weight-loss injection market are Ozempic, Wegovy and Mounjaro. Understandably, there has been a flurry of interest in knowing more about these drugs – the differences between them ...